October 15, 2024 – Page 9

Red Cat Secures $1 Million Contract for its FlightWave Edge 130 Blue

Written by Customer Service on October 15, 2024. Posted in Public Companies.

Company establishes relationship with the United States Army Communications-Electronics Command SAN JUAN, Puerto Rico, Oct. 15, 2024 (GLOBE NEWSWIRE) — Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat”), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, today announced it secured a $1 million contract for its Edge 130 Blue drones from the United States Army Communications-Electronics Command (CECOM). The contract was secured through Noble, a leading provider of global sustainment and operations support for the U.S. Military and civilian government agencies, and was coordinated for procurement by the U.S. Defense Logistics Agency (DLA) on behalf of CECOM. FlightWave, an industry-leading provider of VTOL drone, sensor and software solutions was acquired by Red...

Multiple New Gold Zones Discovered at OKO Project

Written by Customer Service on October 15, 2024. Posted in Public Companies.

New High-Grade Zone Emerging East of Ghanie Main Zone. Ghanie Main deposit continues to grow along strike and is open to depth. OMZ Shear 3 southern extensions intercepted with multiple visible gold showings. TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) — G2 Goldfields Inc. (“G2” or the “Company”) (TSX: GTWO; OTCQX: GUYGF) is pleased to provide an update on its ongoing exploration program at the Company’s 58,000-acre OKO-Aremu gold project, Guyana. G2 currently has five rigs operating at the project, building on the Company’s current mineral resource which is comprised of 922,000 ounces of gold (Indicated) and 1,099,000 ounces (Inferred) [see press release dated April 03, 2024]. G2 continues to expand and define existing gold zones whilst discovering new high grade parallel zones of gold mineralization. The Company intends to issue...

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

Written by Customer Service on October 15, 2024. Posted in Public Companies.

U.S. Food and Drug Administration (FDA) Submission Expected by end of 2024 Clinical Data to be Presented at Medical Conference in Early 2025 BRAINTREE, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announced that it has successfully completed enrollment and follow up for all patients in its ACCESS-PVI human clinical trial. The Company remains on track to file its 510(k) submission with the U.S. Food and Drug Administration (FDA) by of the end of 2024. The Company also announced that it is accelerating its go-to-market strategy. It expects to begin building out the commercial infrastructure, including the hiring of a seasoned healthcare executive to lead its sales efforts, upon the FDA clearance, which is expected during...

Wearable Devices and RayNeo Collaborate to Lead the Industry of Neural Control for AR Glasses

Written by Customer Service on October 15, 2024. Posted in Public Companies.

YOKNEAM ILLIT, ISRAEL, Oct. 15, 2024 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, today announces the collaboration with RayNeo™ (“RayNeo”), a leader in augmented reality (AR) technology, to collaborate in delivering mass production level solution of next-generation neural interface AR glasses. Both parties will be showcasing how neural interface technology can be seamlessly integrated into AR devices, enhancing user experience by enabling hands-free, gesture-based interactions in augmented and mixed reality environments. RayNeo is known for its innovations in AR, developing cutting-edge AR glasses that enhance immersive experiences by overlaying digital...

ZOOZ Power Ltd. to Present at the LD Micro Main Event XVII on Wednesday, October 30, 2024

Written by Customer Service on October 15, 2024. Posted in Public Companies.

Tel Aviv, Oct. 15, 2024 (GLOBE NEWSWIRE) — ZOOZ POWER Ltd. (NASDAQ and TASE: ZOOZ), the leading provider of Flywheel-based power boosting and power management solutions enabling ultra-fast multi ports EV charging, today announced that Erez Zimerman, Chief Executive Officer, will present at the LD Micro Main Event XVII in Los Angeles, on Wednesday, October 30, 2024, at 8:30am PT / 11:30am ET. Representatives of ZOOZ Power’s management will be available on site for one-on-one meetings. To schedule a meeting, please contact LD Micro or Miri Segal at msegal@ms-ir.com. A webcast of the presentation will be streamed live at the following link: https://me24.sequireevents.com/. A replay of the webcast will be available approximately 24 hours after the presentation ends. About ZOOZ Power ZOOZ Power is the leading provider of Flywheel-based...

SELLAS Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to Galinpepimut-S (GPS) for the Treatment of Pediatric Acute Myeloid Leukemia

Written by Customer Service on October 15, 2024. Posted in Public Companies.

– GPS Currently Investigated in Phase 3 REGAL Trial in Adult AML Patients – Interim Analysis Anticipated in Q4 2024 – – RPDD Provides Eligibility for GPS to Receive a Priority Review Voucher (PRV) Upon Marketing Approval that can be Transferred/Sold to Other Parties – – Recent Valuations for PRVs Remain Attractive (~$100 million/each) – NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to Galinpepimut-S (GPS), an immunotherapeutic targeting Wilms Tumor-1 (WT1), for the treatment of pediatric...

JBTC Announces 3rd Quarter 2024 Earnings

Written by Customer Service on October 15, 2024. Posted in Earnings Releases And Operating Results.

JONESTOWN, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) — JBT Bancorp, Inc. (OTCQX: JBTC) reported quarterly earnings of $2,306,000 or $0.94 per share for the third quarter of 2024. Nine-month reported earnings are $5,780,000 or $2.37 per share, up from $5,720,000 or $2.35 per share in the prior year, representing a 1.05% increase in earnings. President & CEO Troy A. Peters stated: “This earnings increase is largely attributable to growing net interest income while actively slowing loan growth and focusing on overall liquidity. Net interest income is up 2.65% year-to-date as funding cost increases slowed during the summer. Most certificates of deposit have been repriced into current rates and the escalating costs of these deposits has leveled off and created a more stable environment.” More information can be found at OTC Markets at...

Bombardier to Report Third Quarter Financial Results on November 7, 2024

Written by Customer Service on October 15, 2024. Posted in Earnings Releases And Operating Results.

MONTRÉAL, Oct. 15, 2024 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) will publish its financial results for the third quarter of 2024 on November 7, 2024. Financial results for the third quarter 2024 Éric Martel, President and Chief Executive Officer, Bombardier, and Bart Demosky, Executive Vice President and Chief Financial Officer, Bombardier, will present the financial results for the third quarter 2024 in a live presentation, followed by a question-and-answer period with analysts. The presentation will take place on November 7, 2024, at 8:00 a.m. ET. To listen in: Live webcast (recommended): A live webcast of the financial results presentation, along with the relevant financial charts, will be available on this webpage (in English and in French). By phone: The presentation can also be accessed by telephone. Phone lines will...

Cosmetic Packaging Market is Estimated to Grow at a CAGR of 3.6% through 2031, Report by SkyQuest Technology

Written by Customer Service on October 15, 2024. Posted in Mergers And Acquisitions.

Rapidly increasing demand for cosmetics and personal care products around the world is slated to drive the demand for cosmetic packaging over the coming years. Westford, USA, Oct. 15, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the global cosmetic packaging market will attain a value of USD 68.74 billion by 2031, with a CAGR of 3.6% over the forecast period (2024-2031). Rapidly increasing demand for cosmetics and personal care products around the world is slated to drive the demand for cosmetic packaging over the coming years. Rising disposable income of people and advancements in packaging technologies are expected to drive the cosmetic packaging market growth. Download a detailed overview: https://www.skyquestt.com/sample-request/cosmetic-packaging-market Browse in-depth TOC on “Cosmetic Packaging Market” Pages...

Customer Journey Analytics Market is Expected to Expand at a Stellar 20.2% CAGR through 2031 | SkyQuest Technology

Written by Customer Service on October 15, 2024. Posted in Mergers And Acquisitions.

Westford,USA, Oct. 15, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Customer Journey Analytics market will attain a value of USD 64.21 billion by 2031, with a CAGR of 20.2% over the forecast period (2024-2031). Evolving consumer preferences around the world have bolstered the demand for enhanced customer experience to boost sales and ensure customer retention. Organizations around the world are turning towards customer journey analytics to improve customer experience and retention and boost their revenue generation capabilities. Download a detailed overview: https://www.skyquestt.com/sample-request/customer-journey-analytics-market Browse in-depth TOC on “Customer Journey Analytics Market” Pages – 197 Tables – 116 Figures – 77 Customer Journey Analytics Market Overview: Report Coverage Details Market...

Day: October 15, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice